KYMR
Kymera Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$117.75
−0.62%0
Insider buys (3m)
127
Insider sells (3m)
-$346.1M
Net value (3m)
+17.6%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 4, 2026 | Adams Brian · officer: Chief Legal Officer | Sale | 3,025 | $117 |
| Sep 4, 2026 | Adams Brian · officer: Chief Legal Officer | Sale | 1,209 | $116 |
| Sep 4, 2026 | Adams Brian · officer: Chief Legal Officer | Sale | 2,137 | $118 |
| Jul 27, 2026 | Rooney Terence · officer: Chief Medical Officer | A-Award | 38,000 | $0.00 |
| Jul 27, 2026 | Rooney Terence · officer: Chief Medical Officer | A-Award | 76,000 | $110 |
| Jul 7, 2026 | Mainolfi Nello · director, officer: Chief Executive Officer | M-Exempt | 4,441 | $2.08 |
| Jul 7, 2026 | Mainolfi Nello · director, officer: Chief Executive Officer | M-Exempt | 45,559 | $2.08 |
| Jul 7, 2026 | Mainolfi Nello · director, officer: Chief Executive Officer | Sale | 50,000 | $119 |
| Jul 7, 2026 | Mainolfi Nello · director, officer: Chief Executive Officer | M-Exempt | 50,000 | $2.08 |
| Jul 2, 2026 | Booth Bruce · director | Sale | 130 | $111 |
| Jul 2, 2026 | Booth Bruce · director | Sale | 934 | $111 |
| Jul 2, 2026 | Mainolfi Nello · director, officer: Chief Executive Officer | Sale | 24,105 | $115 |
| Jul 2, 2026 | Booth Bruce · director | Sale | 1,104 | $110 |
| Jul 2, 2026 | Jacobs Bruce N. · officer: Chief Financial Officer | Sale | 7,971 | $116 |
| Jul 2, 2026 | Booth Bruce · director | Sale | 1,078 | $111 |
| Jul 2, 2026 | Booth Bruce · director | Sale | 770 | $106 |
| Jul 2, 2026 | Mainolfi Nello · director, officer: Chief Executive Officer | Sale | 6,626 | $114 |
| Jul 2, 2026 | Jacobs Bruce N. · officer: Chief Financial Officer | Sale | 1,700 | $112 |
| Jul 2, 2026 | Booth Bruce · director | Sale | 19,419 | $108 |
| Jul 2, 2026 | Booth Bruce · director | Sale | 14,798 | $107 |
| Jul 2, 2026 | Booth Bruce · director | Sale | 2,698 | $108 |
| Jul 2, 2026 | Booth Bruce · director | Sale | 1,498 | $108 |
| Jul 2, 2026 | Booth Bruce · director | Sale | 7,968 | $110 |
| Jul 2, 2026 | Booth Bruce · director | Sale | 10,848 | $108 |
| Jul 2, 2026 | Goodman Noah · officer: Chief Business Officer | Sale | 3,389 | $114 |
| Jul 2, 2026 | Mainolfi Nello · director, officer: Chief Executive Officer | M-Exempt | 80,000 | $2.08 |
| Jul 2, 2026 | Mainolfi Nello · director, officer: Chief Executive Officer | Sale | 44,050 | $116 |
| Jul 2, 2026 | Booth Bruce · director | Sale | 2,133 | $107 |
| Jul 2, 2026 | Booth Bruce · director | Sale | 7,723 | $111 |
| Jul 2, 2026 | Jacobs Bruce N. · officer: Chief Financial Officer | Sale | 6,153 | $117 |
Institutional positioning
13F filings over the trailing two quarters
New 99Increased 194Reduced 160Sold out 27
| Filer | Action | Shares | Filed |
|---|---|---|---|
| FMR LLC | Increased | 12,349,256 | Aug 13, 2026 |
| FMR LLC | Increased | 11,699,950 | May 15, 2026 |
| BAKER BROS. ADVISORS LP | Unchanged | 8,657,242 | May 15, 2026 |
| BAKER BROS. ADVISORS LP | Unchanged | 8,657,242 | Aug 14, 2026 |
| AVORO CAPITAL ADVISORS LLC | Reduced | 7,474,747 | May 15, 2026 |
| Avoro Capital Advisors LLC | Unchanged | 7,474,747 | Aug 14, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 7,112,980 | Aug 14, 2026 |
| T. Rowe Price Investment Management, Inc. | Increased | 6,257,261 | Aug 14, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Reduced | 6,060,847 | May 15, 2026 |
| BlackRock, Inc. | Increased | 5,538,210 | Aug 7, 2026 |
| BVF INC/IL | Unchanged | 5,502,710 | May 15, 2026 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | Increased | 5,464,997 | May 15, 2026 |
| BLACKROCK, INC. | Increased | 5,060,876 | May 13, 2026 |
| ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | Reduced | 4,578,008 | May 14, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Reduced | 3,889,687 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 4, 2026